|
Adams JM and Cory S. The Bcl-2 protein family: arbiters of cell survival.
Science. 281:1322-1326, 1998.
Alessi DR, Saito Y, Campbell DG, Cohen P, Sithanandam G, Rapp U, Ashworth A,
Marshall CJ and Cowley S. Identification of the sites in MAP kinase kinase-1
phosphorylated by p74raf-1. EMBO J. 13(7):1610-1619, 1994.
Aoki H, Kang PM, Hampe J, Yoshimura K, Noma T, Matsuzaki M and Izumo S. Direct
activation of mitochondrial apoptosis machinery by c-Jun N-terminal kinase
in adult cardiac myocytes. J Biol Chem. 277(12):10244-10250, 2002.
Ashkenazi A and Dixit VM. Death receptors: signaling and modulation. Science.
281:1305-1308, 1998.
Brichese L, Cazettes G and Valette A. JNK is associated with Bcl-2 and PP1 in
mitochondria: paclitaxel induces its activation and its association with the
phosphorylated form of Bcl-2. Cell Cycle. 3(10):1312-1319, 2004.
Carre M, Andre N, Carles G, Borghi H, Brichese L, Briand C and Braguer D.
Tubulin is an inherent component of mitochondrial membranes that interacts
with the voltage-dependent anion channel. J Biol Chem. 277(37):33664-33669,
2002.
Chauhan D, Li G, Hideshima T, Podar K, Mitsiades C, Mitsiades N, Munshi N,
Kharbanda S and Anderson KC. JNK-dependent release of mitochondrial protein,
Smac, during apoptosis in multiple myeloma (MM) cells. J Biol Chem. 278
(20):17593-17596, 2003.
Chen YC, Huang YL and Huang BM. Cordyceps sinensis mycelium activates PKA and
PKC signal pathways to stimulate steroidogenesis in MA-10 mouse Leydig tumor
cells. Int J Biochem Cell Biol. 37(1): 214-23, 2005.
Cheng SC, Luo D and Xie Y. Taxol Induced BcL-2 Protein Phosphorylation In
Human Hepatocellular Carcinoma QGY-7703 Cell Line. Cell Biology
international. 25(3): 261-265, 2001.
Crews CM, Alessandrini A and Erikson RL. The primary structure of MEK, a
protein kinase that phosphrylates the ERK and product. Science. 258:478-480,
1992.
Dougherty CJ, Kubasiak LA, Prentice H, Andreka P, Bishopric NH and Webster KA.
Activation of c-Jun N-terminal kinase promotes survival of cardiac myocytes
after oxidative stress. Biochem J. 362(3):561-571, 2002.
Fang GF, Chang BS, Kim CN, Perkins C, Tohmpson CB and Bhalla KN. “Loop”
domain is necessary for taxol-induced mobility shift and phosphorylation of
Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of
cytochrome c and apoptosis. Cancer Res. 89:3202-3208, 1998.
Ferlini C, Raspaglio G, Mozzetti S, Distefano M, filippetti F, Martinelli E,
Ferrandina G, Gallo d, Ranelletti FO and Scambia G. Bcl-2 down-regulation is
a novel mechanism of paclitaxel resistance. Mol Pharmacol. 64:51-58, 2003.
Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, Glisson B,
Trotti A, Ridge JA, Chao C, Peters G, Lee DJ, Leaf A, Ensley J and Cooper J.
Concurrent chemotherapy and radiotherapy for organ preservation in advanced
laryngeal cancer. N Engl J Med. 349(22):2091-2098, 2003.
Gan Y, Wientjes MG, Schuller DE and Au JL. Pharmacodynamics of taxol in human
head and neck tumors. Cancer Res. 56(9):2086-2093, 1996.
Green DR and Reed JC. Mitochondria and apoptosis. Science. 281 (5381):1309-
1312, 1998.
Gupta S. Molecular steps of death receptor and mitochondrial pathways of
apoptosis. Life Sci. 69(25-26):2957-2964, 2001.
Huisman C, Ferreira CG, Broker LE, Rodriguez JA, Smit EF, Postmus PE, Kruyt FA
and Giaccone G. Paclitaxel triggers cell death primarily via caspase-
independent routes in the non-small cell lung cancer cell line NCI-H460.
Clin Cancer Res. 8(2):596-606, 2002.
Kaczirek K, Schindl M, Weinhausel A, Scheuba C, Passler C, Prager G, Raderer
M, Hamilton G, Mittlbock M, Siegl V, Pfragner R and Niederle B. Cytotoxic
activity of camptothecin and paclitaxel in newly established continuous
human medullary thyroid carcinoma cell lines. J Clin Endocrinol Metab. 89
(5):2397-2401, 2004.
Kottke TJ, Blajeski AL, Martins LM, Mesner PW Jr, Davidson NE, Earnshaw WC,
Armstrong DK and Kaufmann SH. Comparison of paclitaxel-, 5-fluoro-2'-
deoxyuridine-, and epidermal growth factor (EGF)-induced apoptosis. Evidence
for EGF-induced anoikis. J Biol Chem. 274(22):15927-15936, 1999.
Lee LF, Li G, Templeton DJ and Ting JP. Paclitaxel (Taxol)-induced gene
expressin and cell death are both mediated by the activation of c-Jun NH2-
terminal kinase (JNK/SAPK). J Biol Chem. 273(43):28253-28360, 1998.
Liao PC and Lieu CH. Cell cycle specific induction of apoptosis and necrosis
by paclitaxel in the leukemic U937 cells. Life Sci. 76:1623-1639, 2005.
Lieu CH, Chang YN and Lai YK. Dual cytotoxic mechanisms of submicromolar taxol
on human leukemia HL-60 cells. Biochemical Pharmacology. 53: 1587–1596,
1997.
Liggett W and Forastiere AA. Chemotherapy advances in head and neck oncology.
Semin Surg Oncol. 11:265-271, 1995.
Lin SC, Liu CJ, Chiu CP, Chang SM, Lu SY and Chen YJ. Establishment of OC3
oral carcinoma cell line and identification of NF-kappa B activation
responses to areca nut extract. J Oral Pathol Med. 33(2):79-86, 2004.
Liu XM, Wang LG, Kreis W, Budman DR and Adams LM. Differential effect of
vinorelbine versus paclitaxel on ERK2 kinase activity during apoptosis in
MCF-7 cells. British Journal of Cancer, 85(9): 1403-1411, 2001.
Marone M, D’Andrilli G, Das N, Ferlini C, Chatterjee S and Scambia G.
Quercetin abrogates taxol-mediated signaling by inhibiting multiple kinases.
Exp Cell Res. 270(1):1-12, 2001.
McDaid HM and Horwitz SB. Selective potentiation of paclitaxel (taxol)-induced
cell death by mitogen-activated protein kinase kinase inhibition in human
cancer cell lines. Mol pharmaco. 60(2):290-301, 2001.
Meng CL, Yang CY, Shen KL, Wong PY and Lee HK. Inhibition of the synthesis of
eicosanoid-like substances in a human oral cancer cell line by interferon-
gamma and eicosapentaenoic acid.
Arch Oral Biol. 43(12):979-86, 1998.
Miller AB, Hoogstraten B, Staquet M and Winkler A. Reporting results of cancer
treatment. Cancer. 47(1):207-214, 1981.
Monnerat C, Faivre S, Temam S, Bourhis J and Raymond E. End points for new
agents in induction chemotherapy for locally advanced head and neck cancers.
Ann Oncol. 13(7):995-1006, 2002.
Nicoletti I, Migliorati G, Pagliacci MC, Grignani F and Riccardi C. A rapid
and simple method for measuring thymocyte apoptosis by propidium iodide
staining and flowcytometry. J Immunol Methods. 139(2):271 279, 1991.
Nicotera P. Apoptosis and age-related disorders: role of caspase- dependent
and caspase-independent pathways. Toxicol Let. 127(1-3):189- 195, 2002.
Nosseri C, Coppola S and Ghibelli L. Possible Involvement of Poly(ADP-Ribosyl)
Polymerase in Triggering Stress-Induced Apoptosis. Exp Cell Res. 212(2): 367-
73, 1994.
Park SJ, Wu CH, Gordon JD, Zhong X, Emami A and Safa AR. Taxol induces caspase-
10-dependent apoptosis. J Biol Chem. 279(49):51057-51067, 2004.
Pignon JP, Bourhis J, Domenge C and Designe L. Chemotherapy added to
locoregional treatment for head and neck squamous-cell carcinoma: three meta-
analyses of updated individual data. MACH-NC Collaborative Group. Meta-
Analysis of Chemotherapy on Head and Neck Cancer. Lancet. 355(9208):949-955,
2000.
Psyrri A, Kwong M, DiStasio S, Lekakis L, Kassar M, Sasaki C, Wilson LD,
Haffty BG, Son YH, Ross DA, Weinberger PM, Chung GG, Zelterman D, Burtness
BA and Cooper DL. Cisplatin, fluorouracil, and leucovorin induction
chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ
preservation and cure in patients with advanced head and neck cancer: long-
term follow-up. J Clin Oncol. 22(15):3061-3069, 2004.
Pushkarev VM, Starenki DV, Saenko VA, Namba H, Kurebayashi J, Tronko MD and
Yamashita S. Molecular mechanisms of the effects of low concentrations of
taxol in anaplastic thyroid cancer cells. Endocrinology. 145(7):3143-3152,
2004.
Rodi DJ, James RW, Sanganee HJ, Holton RA, Wallace BA and Makowski L.
Screening of a library of phage-displayed peptides identifies human Bcl-2 as
a taxol-binding protein. J. Mol. Biol. 285(1):197-203, 1999.
Rowinsky EK and Donehower RC. Paclitaxel (taxol). N Engl J Med. 332(15):1004-
1014, 1995.
Rowinsky EK. The development and clinical utility of the taxane class of
antimicrotubule chemotherapy agents. Annu Rev Med. 48:253-374, 1997.
Seidman R, Gitelman I, Sagi O, Horwitz SB and Wolfson M. The role of ERK 1/2
and p38 MAP-kinase pathways in taxol-induced apoptosis in human ovarian
carcinoma cells. Exp Cell Res. 268(1):84-92, 2001.
Srivastava RK, Sasaki CY, Hardwick JM and Longo DL. Bcl-2-mediated drug
resistance: inhibition of apoptosis by blocking nuclear factor of activated
T lymphocytes (NFAT)-induced Fas ligand transcription. J Exp Med. 190(2):253-
65, 1999.
Stennicke HR and Salvesen GS. Caspases - controlling intracellular signals by
protease zymogen activation. Biochim Biophys Acta. 1477(1-2): 299-306, 2000.
Stumm S, Meyer A, Lindner M, Bastert G, Wallwiener D and Guckel B. Paclitaxel
treatment of breast cancer cell lines modulates Fas/Fas ligand expression
and induces apoptosis which can be inhibited through the CD40 receptor.
Oncology. 66(2):101-11, 2004.
Tishler RB, Schiff PB, Geard CR, and Hall EJ. Taxol: a novel radiation
sensitizer. Int J Radiat Oncol Biol Phys. 22(3):613-617, 1992.
Tobiume K, Matsuzawa A, Takahashi T, Nishitoh H, Morita K, Takeda K, Minowa O,
Miyazono K, Noda T and Ichijo H. ASK1 is required for sustained activations
of JNK/p38 MAP kinases and apoptosis. EMBO Rep. 2(3):222-228, 2001.
von Haefen C, Wieder T, Essmann F, Schulze-Osthoff K, Dorken B and Daniel PT.
Paclitaxel-induced apoptosis in BJAB cells proceeds via a death receptor-
independent, caspases-3/-8-driven mitochondrial amplification loop.
Oncogene. 22(15):2236-2247, 2003.
Wada T and Penninger JM. Mitogen-activated protein kinases in apoptosis
regulation. Oncogene. 23(16):2838-2849, 2004.
Wang LG, Liu XM, Kreis W and Budman DR. The effect of antimicrotubule agents
on signal transduction pathways of apoptosis: a review. Cancer Chemother
Pharmacol. 44(5):355-361, 1999.
Wang TH, Wang HS and Soong YK. Paclitaxel-induced cell death: where the cell
cycle and apoptosis come together. Cancer. 88(11):2619-2628, 2000.
Wang TH, Wang HS, Ichijo H, Giannakakou P, Foster JS, Fojo T and Wimalasena J.
Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-
activated protein kinase through both Ras and apoptosis signal-regulating
kinase pathways. J Biol Chem. 273(9):4928-4936, 1998.
Wu HP, Hsu LP and Chen PR. Treatment of Laryngeal Cancer at Buddhist Tzu Chi
General Hospital. Tzu Chi Med J. 13(2):217-222, 2001.
Yan Zhang, Hai Lu, Paul Dazin and Yvonne Kapila. Squamous cell carcinoma cell
aggregates escape suspension-induced, p53-mediated anoikis: fibronectin and
integrin alphav mediate survival signals through focal adhesion kinase. J
Biol Chem. 279(46):48342-48349, 2004.
Zelivianski S, Spellman M, Kellerman M, Kakitelashvilli V, Zhou XW, Lugo E,
Lee MS, Taylor R, Davis TL, Hauke R and Lin MF. ERK inhibitor PD98059
enhances docetaxel-induced apoptosis of androgen-independent human prostate
cancer cells. Int J Cancer, 107(3): 478-485, 2003.
|